Underrepresentation of women in cardiovascular disease clinical Trials—What’s in a Name?
Representation of female patients in cardiovascular trials does not depend on the perceived gender of the trial acronym but is improved in trials under female leadership in out-patient settings. Our findings may direct efforts towards increasing representation of female patients in cardiovascular trials.
Authors
- Yolande Appelman (ORCID: https://orcid.org/0000-0001-5241-7105)
- Karen Reue (ORCID: https://orcid.org/0000-0002-7487-2624)
- Anne Margje Lisa Naomi van Ommen (ORCID: https://orcid.org/0000-0003-1249-0767)
- Anna E. Spiering (ORCID: https://orcid.org/0000-0002-3815-4991)
- Jeanine E. Roeters van Lennep (ORCID: https://orcid.org/0000-0001-6870-9962)
- N.C. Onland-Moret
- Hester M. den Ruijter (ORCID: https://orcid.org/0000-0001-9762-014X)
Institutions
- University of California, Los Angeles (US)
- Utrecht University (NL)
- Erasmus MC (NL)
- University Medical Center Utrecht (NL)
- Amsterdam Neuroscience (NL)
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- IJC Heart & Vasculature
- Published
- 2024-11-08
- DOI
- https://doi.org/10.1016/j.ijcha.2024.101547
- Citations
- 1
- Primary Topic
- Sex and Gender in Healthcare
- Type
- article
- Field-Weighted Citation Impact
- 0.54
Funders
- Dutch Cardiovascular Alliance
- Fondation Leducq